UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 156

Sortiert nach

Modulation of CYP450 Activities in Patients With Type 2 Diabetes

Clinical pharmacology and therapeutics, 2019-12, Vol.106 (6), p.1280-1289

2019

Volltextzugriff (PDF)

Use of 4β‐Hydroxycholesterol Plasma Concentrations as an Endogenous Biomarker of CYP3A Activity: Clinical Validation in Individuals With Type 2 Diabetes

Clinical pharmacology and therapeutics, 2019-10, Vol.106 (4), p.831-840

2019

Volltextzugriff (PDF)

Oxytocin Treatment Prevents the Cardiomyopathy Observed in Obese Diabetic Male db/db Mice

Endocrinology (Philadelphia), 2015-04, Vol.156 (4), p.1416-1428

2015

Volltextzugriff (PDF)

Rationale for and design of the Acarbose Cardiovascular Evaluation (ACE) trial

The American heart journal, 2014-07, Vol.168 (1), p.23-29.e2

2014

Volltextzugriff (PDF)

Increased urinary excretion of hedgehog interacting protein (uHhip) in early diabetic kidney disease

Translational research : the journal of laboratory and clinical medicine, 2020-03, Vol.217, p.1-10

2020

Volltextzugriff (PDF)

Efficacy of single-hormone and dual-hormone artificial pancreas during continuous and interval exercise in adult patients with type 1 diabetes: randomised controlled crossover trial

Diabetologia, 2016-12, Vol.59 (12), p.2561-2571

2016

Volltextzugriff (PDF)

All-trans retinoic acid stimulates gene expression of the cardioprotective natriuretic peptide system and prevents fibrosis and apoptosis in cardiomyocytes of obese ob/ob mice

Applied physiology, nutrition, and metabolism, 2014-10, Vol.39 (10), p.1127

2014

Volltextzugriff (PDF)

Guidelines for Premeal Insulin Dose Reduction for Postprandial Exercise of Different Intensities and Durations in Type 1 Diabetic Subjects Treated Intensively With a Basal-Bolus Insulin Regimen (Ultralente-Lispro)

Diabetes care, 2001-04, Vol.24 (4), p.625-630

2001

Volltextzugriff (PDF)

Acarbose for prevention of type 2 diabetes mellitus: the STOP-NIDDM randomised trial

The Lancet (British edition), 2002-06, Vol.359 (9323), p.2072-2077

2002

Volltextzugriff (PDF)

Estimating the Population Prevalence of Diagnosed and Undiagnosed Diabetes

Diabetes care, 2013-10, Vol.36 (10), p.3002-3008

2013

Volltextzugriff (PDF)

Acarbose treatment and the risk of cardiovascular disease and hypertension in patients with impaired glucose tolerance: the STOP-NIDDM trial

JAMA : the journal of the American Medical Association, 2003-07, Vol.290 (4), p.486

2003

Volltextzugriff (PDF)

Effects of Insulin Glargine and Liraglutide Therapy on Liver Fat as Measured by Magnetic Resonance in Patients With Type 2 Diabetes: A Randomized Trial

Diabetes care, 2015-07, Vol.38 (7), p.1339-1346

2015

Volltextzugriff (PDF)

Acute Hyperglycemia Induces a Global Downregulation of Gene Expression in Adipose Tissue and Skeletal Muscle of Healthy Subjects

Diabetes (New York, N.Y.), 2007-04, Vol.56 (4), p.992-999

2007

Volltextzugriff (PDF)

Comparison of Two Continuous Glucose Monitoring Systems, Dexcom G4 Platinum and Medtronic Paradigm Veo Enlite System, at Rest and During Exercise

Diabetes technology & therapeutics, 2016-09, Vol.18 (9), p.561

2016

Volltextzugriff (PDF)

Effects of Changing the Amount and Source of Dietary Carbohydrates on Symptoms and Dietary Satisfaction Over a 1-Year Period in Subjects with Type 2 Diabetes: Canadian Trial of Carbohydrates in Diabetes (CCD)

Canadian journal of diabetes, 2017-04, Vol.41 (2), p.164-176

2017

Volltextzugriff (PDF)

Increased Shear Rate Resistance and Fastest Kinetics of Erythrocyte Aggregation in Diabetes Measured With Ultrasound

Diabetes care, 2008-07, Vol.31 (7), p.1400-1402

2008

Volltextzugriff (PDF)

Acarbose for the prevention of diabetes, hypertension, and cardiovascular disease in subjects with impaired glucose tolerance: the Study to Prevent Non-Insulin-Dependent Diabetes Mellitus (STOP-NIDDM) Trial

Endocrine practice, 2006-01, Vol.12 Suppl 1, p.25-30

Chiasson, Jean-Louis

2006

Volltextzugriff (PDF)

The Synergistic Effect of Miglitol Plus Metformin Combination Therapy in the Treatment of Type 2 Diabetes

Diabetes care, 2001-06, Vol.24 (6), p.989-994

2001

Volltextzugriff (PDF)

Early Insulin Use in Type 2 Diabetes: What are the cons?

Diabetes care, 2009-11, Vol.32 (11), p.S270-S274

Chiasson, Jean-Louis

2009

Volltextzugriff (PDF)

The Canadian Trial of Carbohydrates in Diabetes (CCD), a 1-y controlled trial of low-glycemic-index dietary carbohydrate in type 2 diabetes: no effect on glycated hemoglobin but reduction in C-reactive protein

The American journal of clinical nutrition, 2008-01, Vol.87 (1), p.114-125

2008

Volltextzugriff (PDF)

Evaluating the impact of type 2 diabetes mellitus on CYP450 metabolic activities: protocol for a case–control pharmacokinetic study

BMJ open, 2018-02, Vol.8 (2), p.e020922-e020922

2018

Volltextzugriff (PDF)

Glycaemic control, cardiovascular disease, and mortality in type 2 diabetes

The Lancet (British edition), 2014-11, Vol.384 (9958), p.1906-1907

2014

Volltextzugriff (PDF)

The common polymorphisms (single nucleotide polymorphism [SNP] +45 and SNP +276) of the adiponectin gene predict the conversion from impaired glucose tolerance to type 2 diabetes : The STOP-NIDDM trial

Diabetes (New York, N.Y.), 2005-03, Vol.54 (3), p.893-899

2005

Volltextzugriff (PDF)

Hedgehog Interacting Protein Promotes Fibrosis and Apoptosis in Glomerular Endothelial Cells in Murine Diabetes

Scientific reports, 2018-04, Vol.8 (1), p.5958-10, Article 5958

2018

Volltextzugriff (PDF)

Efficacy and safety of inhaled insulin (Exubera) compared with subcutaneous insulin therapy in patients with type 2 diabetes results of a 6-month, randomized, comparative trial

Diabetes care, 2004-10, Vol.27 (10), p.2356-2362

2004

Volltextzugriff (PDF)

1 – 25 von 156

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(145)
Mit Volltextzugriff
(134)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(89)
Life Sciences & Biomedicine
(87)
Humans
(81)
Male
(63)
Biological And Medical Sciences
(59)
Female
(54)
Endocrinology & Metabolism
(50)
Medical Sciences
(47)
Diabetes
(39)
Middle Aged
(36)
Adult
(32)
Blood Glucose - Metabolism
(30)
Hypoglycemic Agents - Therapeutic Use
(28)
Diabetes. Impaired Glucose Tolerance
(26)
Endocrine Pancreas. Apud Cells
(26)
Endocrinopathies
(26)
Insulin
(24)
Animals
(23)
Glucose
(22)
Pharmacology. Drug Treatments
(19)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Modulation of CYP450 Activities in Patients With Type 2 Diabetes

Use of 4β‐Hydroxycholesterol Plasma Concentrations as an Endogenous Biomarker of CYP3A Activity: Clinical Validation in Individuals With Type 2 Diabetes

Oxytocin Treatment Prevents the Cardiomyopathy Observed in Obese Diabetic Male db/db Mice

Rationale for and design of the Acarbose Cardiovascular Evaluation (ACE) trial

Increased urinary excretion of hedgehog interacting protein (uHhip) in early diabetic kidney disease

Efficacy of single-hormone and dual-hormone artificial pancreas during continuous and interval exercise in adult patients with type 1 diabetes: randomised controlled crossover trial

All-trans retinoic acid stimulates gene expression of the cardioprotective natriuretic peptide system and prevents fibrosis and apoptosis in cardiomyocytes of obese ob/ob mice

Guidelines for Premeal Insulin Dose Reduction for Postprandial Exercise of Different Intensities and Durations in Type 1 Diabetic Subjects Treated Intensively With a Basal-Bolus Insulin Regimen (Ultralente-Lispro)

Acarbose for prevention of type 2 diabetes mellitus: the STOP-NIDDM randomised trial

Estimating the Population Prevalence of Diagnosed and Undiagnosed Diabetes

Acarbose treatment and the risk of cardiovascular disease and hypertension in patients with impaired glucose tolerance: the STOP-NIDDM trial

Effects of Insulin Glargine and Liraglutide Therapy on Liver Fat as Measured by Magnetic Resonance in Patients With Type 2 Diabetes: A Randomized Trial

Acute Hyperglycemia Induces a Global Downregulation of Gene Expression in Adipose Tissue and Skeletal Muscle of Healthy Subjects

Comparison of Two Continuous Glucose Monitoring Systems, Dexcom G4 Platinum and Medtronic Paradigm Veo Enlite System, at Rest and During Exercise

Effects of Changing the Amount and Source of Dietary Carbohydrates on Symptoms and Dietary Satisfaction Over a 1-Year Period in Subjects with Type 2 Diabetes: Canadian Trial of Carbohydrates in Diabetes (CCD)

Increased Shear Rate Resistance and Fastest Kinetics of Erythrocyte Aggregation in Diabetes Measured With Ultrasound

Acarbose for the prevention of diabetes, hypertension, and cardiovascular disease in subjects with impaired glucose tolerance: the Study to Prevent Non-Insulin-Dependent Diabetes Mellitus (STOP-NIDDM) Trial

The Synergistic Effect of Miglitol Plus Metformin Combination Therapy in the Treatment of Type 2 Diabetes

Early Insulin Use in Type 2 Diabetes: What are the cons?

The Canadian Trial of Carbohydrates in Diabetes (CCD), a 1-y controlled trial of low-glycemic-index dietary carbohydrate in type 2 diabetes: no effect on glycated hemoglobin but reduction in C-reactive protein

Evaluating the impact of type 2 diabetes mellitus on CYP450 metabolic activities: protocol for a case–control pharmacokinetic study

Glycaemic control, cardiovascular disease, and mortality in type 2 diabetes

The common polymorphisms (single nucleotide polymorphism [SNP] +45 and SNP +276) of the adiponectin gene predict the conversion from impaired glucose tolerance to type 2 diabetes : The STOP-NIDDM trial

Hedgehog Interacting Protein Promotes Fibrosis and Apoptosis in Glomerular Endothelial Cells in Murine Diabetes

Efficacy and safety of inhaled insulin (Exubera) compared with subcutaneous insulin therapy in patients with type 2 diabetes results of a 6-month, randomized, comparative trial

Suchergebnisse filtern